Free Trial
OTCMKTS:NWPHF

Newron Pharmaceuticals (NWPHF) Stock Price, News & Analysis

Newron Pharmaceuticals logo
$9.36 0.00 (0.00%)
(As of 11/22/2024 ET)

About Newron Pharmaceuticals Stock (OTCMKTS:NWPHF)

Key Stats

Today's Range
$9.36
$9.36
50-Day Range
$9.36
$9.36
52-Week Range
$9.10
$12.00
Volume
N/A
Average Volume
600 shs
Market Capitalization
$167.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea. The company's product pipeline includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. In addition, it has a strategic partnership with Zambon for the commercialization of safinamide; and license agreement with Meiji Seika Pharma Co., Ltd., for research, develop, manufacture, and marketing of safinamide. The company was founded in 1999 and is headquartered in Bresso, Italy.

Receive NWPHF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Newron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NWPHF Stock News Headlines

Newron presents H1 2024 results and provides business update
EQS-News: Newron presents H1 2024 results and provides business update
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…
Newron Pharmaceuticals SpA (NWRN)
See More Headlines

NWPHF Stock Analysis - Frequently Asked Questions

Newron Pharmaceuticals' stock was trading at $5.22 on January 1st, 2024. Since then, NWPHF shares have increased by 79.3% and is now trading at $9.36.
View the best growth stocks for 2024 here
.

Shares of NWPHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
11/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:NWPHF
CIK
N/A
Employees
22
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.82 million
Book Value
$0.21 per share

Miscellaneous

Free Float
N/A
Market Cap
$167.08 million
Optionable
Not Optionable
Beta
0.53

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (OTCMKTS:NWPHF) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners